Global Gene Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Indication Type;

Cancer, Cardiovascular Indication, Infectious diseases indication, Genetic diseases indication, Neurological diseases indication, and Others.

By Technology;

Adeno Virus Vector, Adeno-associated Virus Vector, Lentiviral Vector, Retroviral Vector, Herpes Virus Vector, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn716626116 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Gene Therapy Market (USD Million), 2021 - 2031

In the year 2023, the Global Gene Therapy Market was valued at USD 4,320.27 million. The size of this market is expected to increase to USD 21,782.36 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 26.0%.

Gene therapy holds immense potential to address unmet medical needs and transform the treatment paradigm by targeting the underlying cause of diseases at the genetic level. By delivering therapeutic genes or gene-modifying agents into target cells, gene therapy offers the possibility of correcting genetic defects, restoring normal cellular functions, and even eradicating diseases altogether. This paradigm shift from conventional symptomatic treatments to curative therapies represents a fundamental breakthrough in medicine, with profound implications for patients, healthcare providers, and society as a whole.

The market for gene therapy is propelled by several key factors driving its rapid expansion. Technological advancements, particularly in viral and non-viral vector systems for gene delivery, have significantly enhanced the safety, efficacy, and scalability of gene therapy approaches. Moreover, regulatory agencies worldwide have shown increasing support and willingness to expedite the development and approval of gene therapy products, recognizing their transformative potential in addressing unmet medical needs.

The growing investment from biopharmaceutical companies, academic institutions, and government initiatives has catalyzed research and development efforts in gene therapy, leading to a robust pipeline of novel therapeutics targeting a diverse array of diseases. Additionally, the rising prevalence of genetic disorders, cancer, and chronic diseases, coupled with the aging population and increasing healthcare expenditure, underscores the urgent need for innovative treatment modalities like gene therapy.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Indication Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Region
  4. Global Gene Therapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Pipeline of Gene Therapy Products

        2. Clinical Success and Regulatory Approvals

        3. Rising Prevalence of Genetic Disorders and Chronic Diseases

      2. Restraints
        1. Safety Concerns and Adverse Events

        2. High Development Costs

        3. Limited Clinical Evidence and Market Access

      3. Opportunities
        1. Expanded Applications

        2. Precision Medicine

        3. Gene Editing Technologies

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Gene Therapy Market, By Indication Type, 2021 - 2031 (USD Million)
      1. Cancer

      2. Cardiovascular Indication

      3. Infectious diseases indication

      4. Genetic diseases indication

      5. Neurological diseases indication

      6. Others

    2. Global Gene Therapy Market, By Technology, 2021 - 2031 (USD Million)
      1. Adeno Virus Vector

      2. Adeno-associated Virus Vector

      3. Lentiviral Vector

      4. Retroviral Vector

      5. Herpes Virus Vector

      6. Others

    3. Global Gene Therapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Gilead Sciences, Inc.
      2. Novartis
      3. Amgen Inc.
      4. Bluebird Bio
      5. Biogen Inc
  7. Analyst Views
  8. Future Outlook of the Market